These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32101645)

  • 21. Pulmonary rehabilitation for respiratory disorders other than chronic obstructive pulmonary disease.
    Rochester CL; Fairburn C; Crouch RH
    Clin Chest Med; 2014 Jun; 35(2):369-89. PubMed ID: 24874132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary function testing in interstitial lung diseases.
    Chetta A; Marangio E; Olivieri D
    Respiration; 2004; 71(3):209-13. PubMed ID: 15133338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
    Frank AL; Kreuter M; Schwarzkopf L
    Respir Med; 2019 Jun; 152():25-31. PubMed ID: 31128606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey.
    Olson A; Hartmann N; Patnaik P; Wallace L; Schlenker-Herceg R; Nasser M; Richeldi L; Hoffmann-Vold AM; Cottin V
    Adv Ther; 2021 Feb; 38(2):854-867. PubMed ID: 33315170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of success for pulmonary rehabilitation in patients awaiting lung transplantation.
    Kenn K; Gloeckl R; Soennichsen A; Sczepanski B; Winterkamp S; Boensch M; Welte T
    Transplantation; 2015 May; 99(5):1072-7. PubMed ID: 25393161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature.
    Ferri C; Manfredi A; Sebastiani M; Colaci M; Giuggioli D; Vacchi C; Della Casa G; Cerri S; Torricelli P; Luppi F
    Autoimmun Rev; 2016 Jan; 15(1):61-70. PubMed ID: 26384526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interstitial lung diseases in the hospitalized patient.
    Disayabutr S; Calfee CS; Collard HR; Wolters PJ
    BMC Med; 2015 Sep; 13():245. PubMed ID: 26407727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using 6-Min Walk Distance Expressed as a Percentage of Reference to Evaluate the Effect of Pulmonary Rehabilitation in Elderly Patients With Interstitial Lung Disease.
    Igarashi A; Iwanami Y; Sugino K; Gocho K; Homma S; Ebihara S
    J Cardiopulm Rehabil Prev; 2018 Sep; 38(5):342-347. PubMed ID: 29485525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease.
    Huppmann P; Sczepanski B; Boensch M; Winterkamp S; Schönheit-Kenn U; Neurohr C; Behr J; Kenn K
    Eur Respir J; 2013 Aug; 42(2):444-53. PubMed ID: 23100507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary rehabilitation and noninvasive ventilation in patients with hypercapnic interstitial lung disease.
    Dreher M; Ekkernkamp E; Schmoor C; Schoenheit-Kenn U; Winterkamp S; Kenn K
    Respiration; 2015; 89(3):208-13. PubMed ID: 25677159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rehabilitation in non-COPD: mechanisms of exercise limitation and pulmonary rehabilitation for patients with pulmonary fibrosis/restrictive lung disease.
    Markovitz GH; Cooper CB
    Chron Respir Dis; 2010; 7(1):47-60. PubMed ID: 19880656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial.
    Perez-Bogerd S; Wuyts W; Barbier V; Demeyer H; Van Muylem A; Janssens W; Troosters T
    Respir Res; 2018 Sep; 19(1):182. PubMed ID: 30236104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis.
    Schwarzkopf L; Witt S; Waelscher J; Polke M; Kreuter M
    Respir Res; 2018 Apr; 19(1):73. PubMed ID: 29695236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do we need a practice incremental shuttle walk test for patients with interstitial lung disease referred for pulmonary rehabilitation?
    Johnson-Warrington V; Sewell L; Morgan M; Singh S
    Respirology; 2015 Apr; 20(3):434-8. PubMed ID: 25615527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of pulmonary rehabilitation in restrictive lung disease.
    Naji NA; Connor MC; Donnelly SC; McDonnell TJ
    J Cardiopulm Rehabil; 2006; 26(4):237-43. PubMed ID: 16926688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
    Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
    Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pulmonary rehabilitation in patients with fibrotic interstitial lung disease].
    Shi YJ; Lian H; Chen RX; Wang MQ; Huang H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Oct; 58(10):1501-1507. PubMed ID: 39428234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD.
    Du Plessis JP; Fernandes S; Jamal R; Camp P; Johannson K; Schaeffer M; Wilcox PG; Guenette JA; Ryerson CJ
    Respirology; 2018 Apr; 23(4):392-398. PubMed ID: 29193512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of pulmonary rehabilitation on functional exercise capacity and hypoxemia in patients with interstitial lung diseases: a retrospective study.
    Fuschillo S; Felice A; Elia A; Martucci M; Gaudiosi C; Vitali D; Maniscalco M
    Sarcoidosis Vasc Diffuse Lung Dis; 2018; 35(3):245-251. PubMed ID: 32476909
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of comorbidities and impact on pulmonary rehabilitation outcomes.
    Butler SJ; Li LSK; Ellerton L; Gershon AS; Goldstein RS; Brooks D
    ERJ Open Res; 2019 Oct; 5(4):. PubMed ID: 31832430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.